- cafead   Jun 25, 2024 at 11:52: AM
via Eli Lilly is teaming up with OpenAI on a quest to develop new treatments that overcome antimicrobial resistance (AMR).
The Big Pharma will use the generative artificial intelligence from OpenAI to come up with new solutions for microbial infections. Financial details of the deal, which was announced June 25, were not disclosed.
article source
The Big Pharma will use the generative artificial intelligence from OpenAI to come up with new solutions for microbial infections. Financial details of the deal, which was announced June 25, were not disclosed.
article source